Clinical Trials
3 trialsNCT01445340 2019-12-17
Topical Romidepsin to Treat Early-Stage Cutaneous T-Cell Lymphoma
National Institutes of Health Clinical Center (CC)
Phase 1 Terminated
NCT00007345 2017-05-16
Depsipeptide to Treat Patients With Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00019318 2015-04-29
Depsipeptide in Treating Patients With Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed